Table 1 Diabetic retinopathy in Xavante Indians according to clinical and laboratory data
Variable | Diabetic retinopathy | p valuea | |
|---|---|---|---|
Yes (n = 27) | No (n = 113) | ||
Mean (min–max) | Mean (min–max) | ||
Diabetes duration (months) | 77.1 (12–180) | 28.7 (0–132) | < 0.01 |
Fasting glucose (mg/dL) | 356.4 (230–600) | 219.7 (72–600) | < 0.01b |
Total cholesterol (mg/dL) | 162.5 (124–280) | 148.4 (15–378) | 0.06b |
Triglycerides (mg/dL) | 309.9 (88–3654) | 220.3 (53–1981) | 0.02b |
HDL cholesterol (mg/dL) | 40.0 (26.0–63.0) | 39.3 (23.6–59.0) | 0.63b |
LDL cholesterol (mg/dL) | 75.4 (10–140) | 69.2 (27–116) | 0.32 |
C-reactive protein (mg/L) | 2.92 (0.48–41.44) | 3.78 (0.35–83.05) | 0.28b |
HbA1c (%) | 12.5 (8.2–16.0) | 9.76 (5.5–18.8) | < 0.01b |
Microalbuminuria (mg/L) | 49.8 (2.2–778) | 17.2 (1.1–5190) | < 0.01b |
Apolipoprotein A–I (mg/dL) | 114.1 (96.8–143) | 110.7 (73–229.2) | 0.23b |
Apolipoprotein B (mg/dL) | 71.4 (30.4–113) | 75.2 (38–134) | 0.42b |